← Open Payments lookup

CAROLYN PIGNATARO: Open Payments

NPI 1780227991 · CHEYENNE, WY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$350 in 11 payments from 6 companies in 2025. Trend: 2023 $258 · 2024 $617 · 2025 $350

Food & beverage: $350
CompanyPaymentsAmount
Alkermes, Inc.4$109
Teva Pharmaceuticals USA, Inc.2$86
Neurocrine BioSciences, Inc.2$86
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$33
E.R. Squibb & Sons, L.L.C.1$22
ABBVIE INC.1$14

Products named: INGREZZA, ARISTADA, UZEDY, CAPLYTA, LYBALVI, COBENFY, AUSTEDO XR, VRAYLAR.

Industry payments across WY — which companies pay providers there.